NCT00624013View on ClinicalTrials.gov

Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.

PHASE4CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
DiabetesDepression
Interventions
DRUG

sertraline

50 mg up to 100 mg daily for 6 months

DRUG

Placebo

50 mg up to 100 mg daily for 6 months

Trial Locations (1)

90059

Charles Drew University, Los Angeles

All Listed Sponsors
lead

Charles Drew University of Medicine and Science

OTHER

NCT00624013 - Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life. | Biotech Hunter | Biotech Hunter